CRE

News Story:

OpGen Helps District of Columbia Hospitals
Combat CRE

Watch NBC News4

hospital bed

Multidrug-resistant organisms (MDROs)
are a growing global threat.

  • Threat to millions of hospital patients
  • Cost US billions of $$ each year, kills thousands
  • Effective antibiotics are scarce

Learn More

dna helix

Vital for Preventing and
Managing MDRO Infections

  • Acuitas® Tests identify “superbug” genes, more
    sensitive and specific than culture
  • Acuitas Lighthouse™ will guide preventative actions
  • Improve outcomes, reduce length of stay

Info about Acuitas® MDRO Tests

doctor

Get ahead of MDROs:

Learn about Acuitas® MDRO Tests and
Acuitas Lighthouse™ MDRO Management System
Learn More

Upcoming Event

IDWeek
New Orleans
October 26th – 30th

Event Calendar

Peer-Reviewed Articles

Browse more than 100 peer-reviewed articles from researchers who are using Genomic Services from OpGen

See References

Press Release

OpGen and District of Columbia Hospital Association Complete First Citywide Quantification of Multidrug-Resistant Organism (MDRO) Prevalence in Washington, D.C.-based Healthcare Facilities

See Press Release

Complete Solutions for Microbial Genetic Analysis

OpGen is dedicated to positively influencing individual healthcare outcomes, enhancing public health, and advancing scientific research by delivering precise, actionable information and results. We offer comprehensive multi-parameter screening and surveillance panels to combat current and emerging multi-drug resistant organisms (MDRO) including carbapenem resistant enterobacteriaceae (CRE) with the next generation of diagnostic and epidemiologic solutions.